StockData
MLTXNasdaqPharmaceutical PreparationsFiscal year ends December 31

MoonLake Immunotherapeutics

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$9.75+0.20 (+2.09%)

Close on Oct 19, 2026

Market cap
$720.67M
P/E (TTM)
–
Dividend yield
–

SEC filings

40 of MoonLake Immunotherapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KSep 30, 2026Sep 30, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 10, 2026SEC EDGAR
Current report8-KAug 10, 2026Aug 10, 2026SEC EDGAR
Current report8-KJul 14, 2026Jul 15, 2026SEC EDGAR
Current report8-KJun 23, 2026Jun 25, 2026SEC EDGAR
Current report8-KJun 21, 2026Jun 22, 2026SEC EDGAR
Current report8-KJun 4, 2026Jun 9, 2026SEC EDGAR
Current report8-KMay 22, 2026Jun 1, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 11, 2026SEC EDGAR
Current report8-KMay 10, 2026May 11, 2026SEC EDGAR
Proxy statementDEF 14AJun 4, 2026Apr 21, 2026SEC EDGAR
Annual report10-KDec 31, 2025Feb 25, 2026SEC EDGAR
Current report8-KFeb 18, 2026Feb 23, 2026SEC EDGAR
Current report8-KJan 8, 2026Jan 8, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 5, 2025SEC EDGAR
Current report8-KNov 5, 2025Nov 5, 2025SEC EDGAR
Current report8-KNov 5, 2025Nov 5, 2025SEC EDGAR
Current report8-KSep 29, 2025Sep 29, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 5, 2025SEC EDGAR
Current report8-KAug 5, 2025Aug 5, 2025SEC EDGAR
Current report8-KJun 5, 2025Jun 6, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 12, 2025SEC EDGAR
Current report8-KMay 12, 2025May 12, 2025SEC EDGAR
Current report8-KApr 29, 2025Apr 29, 2025SEC EDGAR
Proxy statementDEF 14AJun 5, 2025Apr 22, 2025SEC EDGAR
Current report8-KMar 31, 2025Apr 3, 2025SEC EDGAR
Annual report10-KDec 31, 2024Feb 26, 2025SEC EDGAR
Current report8-KFeb 26, 2025Feb 26, 2025SEC EDGAR
Current report8-KDec 12, 2024Dec 18, 2024SEC EDGAR
Quarterly report10-QSep 30, 2024Nov 7, 2024SEC EDGAR
Current report8-KNov 7, 2024Nov 7, 2024SEC EDGAR
Current report8-KSep 11, 2024Sep 11, 2024SEC EDGAR
Quarterly report10-QJun 30, 2024Aug 7, 2024SEC EDGAR
Current report8-KAug 7, 2024Aug 7, 2024SEC EDGAR
Current report8-KJun 10, 2024Jun 10, 2024SEC EDGAR
Current report8-KJun 5, 2024Jun 6, 2024SEC EDGAR
Quarterly report10-QMar 31, 2024May 7, 2024SEC EDGAR
Current report8-KMay 7, 2024May 7, 2024SEC EDGAR
Annual report, amended10-K/ADec 31, 2023May 7, 2024SEC EDGAR
Proxy statementDEF 14AJun 5, 2024Apr 24, 2024SEC EDGAR